IMPROVING ANTIHYPERTENSIVE THERAPY ADHERENCE IN OBSESE HYPERTENSIVE PREGNANCY

CHYNDIKA ARTAMEVIA, Triana Septianti Purwanto, Sunarto Sunarto

Abstract


Hypertension during pregnancy remains a major contributor to maternal and perinatal morbidity, particularly among women with obesity. Low adherence to antihypertensive therapy may worsen blood pressure control and increase the risk of complications such as preeclampsia, fetal growth restriction, and preterm birth. This study aimed to describe the implementation of comprehensive midwifery care to improve adherence to antihypertensive therapy in a pregnant woman with obesity and hypertension. A case report design was used involving a 26-year-old primigravida at 31–32 weeks of gestation with obesity (BMI 35.38 kg/m²), hypertension (blood pressure 150/80 mmHg), low knowledge regarding hypertension (HK-LS score 54.54%), and low medication adherence (MMAS-8 score 2.5). Data were collected through interviews, physical examinations, observation, medical record reviews, and continuous monitoring during antenatal visits at Puskesmas Plaosan, Magetan. Midwifery interventions included health education regarding hypertension in pregnancy, counseling on the importance of antihypertensive therapy, medication reminder strategies using observation sheets and alarms, family involvement, dietary counseling, physical activity recommendations, and regular blood pressure monitoring. Following the intervention, the client demonstrated improved adherence to therapy, increased understanding of hypertension management, and more consistent medication use. Blood pressure gradually decreased from 150/80 mmHg to 120/80 mmHg, and no signs of severe maternal or fetal complications were identified during the observation period. Comprehensive midwifery care contributed to improved adherence to antihypertensive therapy and supported better maternal health outcomes in an obese pregnant woman with hypertension.

References


L. Lushinta, F. I. T. Patty, D. I. Virawati, and E. Anggraini, “The Effect of Assessment Mean Arterial Pressure and Body Mass Index as an Early Detection of Pre-Eclampsia,” Jurnal Kebidanan, vol. 12, no. 2, pp. 136–143, 2022, doi: 10.31983/jkb.v12i2.9207.

J. Lourenço and L. Guedes-Martins, “Pathophysiology of Maternal Obesity and Hypertension in Pregnancy,” Journal of Cardiovascular Development and Disease, vol. 12, no. 3, art. 91, 2025, doi: 10.3390/jcdd12030091.

M. Alston, L. Redman, and J. Sones, “An Overview of Obesity, Cholesterol, and Systemic Inflammation in Preeclampsia,” Nutrients, vol. 14, no. 10, art. 2087, 2022, doi: 10.3390/nu14102087.

M. Burnier and B. M. Egan, “Adherence in Hypertension,” Circulation Research, vol. 124, no. 7, pp. 1124–1140, 2019, doi: 10.1161/CIRCRESAHA.118.313220.

E. Marliana, A. Suharto, and A. H. Ngestiningrum, “Determinan Gangguan Hipertensi dalam Kehamilan di Wilayah Kerja Puskesmas Maospati Kabupaten Magetan,” Gema Bidan Indonesia, vol. 10, no. 2, pp. 64–70, 2021, doi: 10.36568/gebindo.v10i2.9.

Malka, Mutmainnah, Musni, and Muliani, “Faktor-Faktor yang Berhubungan dengan Hipertensi Gestasional,” Poltekita: Jurnal Ilmu Kesehatan, vol. 15, no. 4, pp. 333–339, 2022, doi: 10.33860/jik.v15i4.679.

Y. P. P. Panca, E. P. Sari, P. L. N. Indriani, and R. Dhamayanti, “Pengaruh Riwayat Hipertensi, Frekuensi Kunjungan ANC, dan Obesitas terhadap Kejadian Preeklampsia pada Ibu Hamil,” Cendekia Medika: Jurnal STIKES Al-Ma’arif Baturaja, vol. 9, no. 1, pp. 17–24, 2024, doi: 10.52235/cendekiamedika.v9i1.268.

L. Pratiwi, Hasbiah, and E. Afrika, “Hubungan Usia, Paritas, dan Riwayat Hipertensi terhadap Terjadinya Hipertensi Gestasional pada Ibu Hamil di Puskesmas Babat,” PREPOTIF: Jurnal Kesehatan Masyarakat, vol. 6, no. 1, pp. 590–596, 2022, doi: 10.31004/prepotif.v6i1.2993.

H. Z. Fakhriantono, N. D. Ariningtyas, K. Prahasanti, and E. N. Sucahyo, “Hubungan antara Obesitas dengan Kejadian Preeklamsia Berat pada Ibu Hamil Trimester 3 di RS Fatimah Kabupaten Lamongan,” Jurnal Medis Umum, vol. 2, no. 3, 2025, doi: 10.30651/jmu.v2i3.28584.

E. G. Gita Maringga, N. A. Wahyuni, and W. W. Astuti, “Pendampingan Ibu Hamil Obesitas dengan Asuhan Berkesinambungan,” ABHIPRAYA: Jurnal Pengabdian Masyarakat Kesehatan dan Sains, vol. 1, no. 2, pp. 41–49, 2024, doi: 10.29407/abhipraya.v1i2.22931.

S. Laksono, M. S. Masrie, and colleagues, “Hipertensi dalam Kehamilan: Tinjauan Narasi,” Herb-Medicine Journal, vol. 5, no. 2, pp. 27–39, 2022, doi: 10.30595/hmj.v5i2.13043.

I. Sholihatin, R. Murniati, F. N. Alami, and Z. V. Aziri, “Understanding Hypertension during Pregnancy: Risk Factors and Prevention Strategies,” Jurnal Biologi Tropis, vol. 24, no. 1, pp. 342–348, 2024, doi: 10.29303/jbt.v24i1b.7940.

R. Alvionita, I. Samidah, and Murwati, “Faktor-Faktor yang Berhubungan dengan Kejadian Hipertensi Kehamilan di RSUD Curup Tahun 2022,” Journal of Nursing and Public Health, vol. 10, no. 2, pp. 198–209, 2022.

American College of Obstetricians and Gynecologists, “Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin No. 222,” Obstetrics & Gynecology, vol. 135, no. 6, pp. e237–e260, 2020.

World Health Organization, WHO Recommendations: Drug Treatment for Non-Severe Hypertension in Pregnancy. Geneva, Switzerland: World Health Organization, 2020.

Dinas Kesehatan Kabupaten Magetan, Profil Kesehatan Kabupaten Magetan Tahun 2023. Magetan, Indonesia: Dinas Kesehatan Kabupaten Magetan, 2023.

Kementerian Kesehatan Republik Indonesia, Pedoman Pengendalian Hipertensi di Fasilitas Kesehatan Tingkat Pertama 2024. Jakarta, Indonesia: Kementerian Kesehatan Republik Indonesia, 2024.




DOI: https://doi.org/10.33846/%25x

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

ISSN: 2621-8224 ----- Publisher: Alliance of Health Activists (AloHA) ----- Address: Jl. Ngurah Rai 18, Bangli, Bali, Indonesia